CHEMPLASTS / Q4-FY26 / claim-ledger

Audit the questions that mattered.

Chemplast Sanmar · Analyst questions, management answers, and the quality of the response where the ledger is available.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

NegativeQ4-FY26 · 2026-05-15Back to quarter ↗

Questions audited

12

Answered directly

67%

Numeric claims

0

Consistency

Question ledger

What was answered, and how?

Sanjay Chen · ICC Security

partial

Trend in suspension PVC spreads and outlook for FY27

we are looking at a spread which is at a neutral level on a replacement cost basis... we may get into a positive side... there could be uncertainties as we go into this quarter.

Sanjay Chen · ICC Security

direct

Growth outlook for specialty chemicals and R32 capacity

the 45 molecules includes 17 that are commercial... the outlook is strong... we are now on the verge of getting into the expansion... by the end of the year as committed earlier 14 KT capacity.

Ankur Pial · Access Capital

partial

Update on CDMO pricing pressure and product pipeline

our model is innovators... we have not been impacted by what's been going on in the generic space... it's just a delay in terms of how those launches have been going on.

Ankur Pial · Access Capital

partial

Timeline for reaching Rs 1,000 crore specialty revenue

we still keep that intact... hopefully next year we will be at that number based on what I have in the pipeline and the products we have commercialized we stand a good chance of getting there.

Ankur Pial · Access Capital

direct

Will SPVC profitability remain under pressure until anti-dumping duty is implemented?

as of today under the given circumstances yes but then there are other measures non-trade measures like QCOs... which will help us in the short to medium term.

Nikhil Gandhi · Bajaj Life Insurance

direct

Nature of Rs 150 crore exceptional item and Q1 outlook

this is the difference between the actual cost and the net salable value which we have provided as of 31st March and it's getting reversed during the current quarter... hopefully things improve post 30th June.

Nikhil Gandhi · Bajaj Life Insurance

evasive

Impairment loss on SPVC and expected improvement in FY27-28

impairment is always done based on at a point in time what is your view... the best estimate has been used... if things improve over a period of time obviously this impairment will get reviewed.

Rohit Nagraj · 361 Capital

direct

Domestic SPVC demand, raw material sustainability, and anti-dumping filing status

demand has been muted... about percentage point below last year... we are constantly looking at different ways and means of mitigating this risk... we will be filing in the near future for the ADD.

Rohit Nagraj · 361 Capital

partial

R32 export strategy and timeline

the go to market strategy always considered a combination of domestic and export... we are working with a few partners... we should be able to crack this part of the puzzle.

Madhurati · Counter Cyclical Investments

direct

Impact of anti-dumping duty and renewable energy JV on SPVC spreads

the suspension PVC is not power intensive... that contract will more benefit the VAC business not the suspension PVC business... the current situation is reasonably volatile... we are breaking even.

Madhurati · Counter Cyclical Investments

declined

Revenue potential from 17 LOIs in specialty chemicals

we would refrain from giving a guidance on what would come out of the LOI... we have signed LOI for six products... I would sort of refrain from giving a guidance on how the total volume value of business.

Jatin Takers · M3 Investment Private Limited

direct

Mandate of the newly formed committee and future capex strategy

we thought it is important that we look at the business as a whole and see how best we can reorganize the business going forward and create value unlock value for all the stakeholders. That's the broad objective.